Applications of CRISPR screening to lung cancer treatment
Frontiers in Cell and Developmental Biology · 15.12.2023 · 11
DOI: 10.3389/fcell.2023.1295555 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Cell and Developmental Biology, online erschienen am 15.12.2023. Verfasst von Wanying Shen und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Taihe Hospital, Hubei University of Medicine, Shiyan, Hubei, China. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Lung cancer is an extremely aggressive and highly prevalent disease worldwide, and it is one of the leading causes of cancer death. Deciphering intrinsic genetic mechanism, finding new targets, and overcoming drug resistance are the key to lung cancer treatment. High-throughput CRISPR screening has been extensively used to obtain the genes related to cancers including lung cancer. This review describes CRISPR/Cas9 or CRISPR/dCas9-based technologies for high-throughput screening. We summarize the applications of CRISPR screening technology in exploring the mechanism of lung cancer development in vivo or in vitro , overcoming drug resistance, improving the effect of immunotherapy, and discovering new therapeutic targets. This review highlights the potential of CRISPR screening in combination with tumor barcoding and high-throughput sequencing (Tuba-seq) to precisely quantify the impact of alterations in many tumor suppressor genes on lung cancer.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurosurgery, Taihe Hospital, Hubei University of Medicine, Shiyan, Hubei, China.
- Hubei Hongshan Laboratory, College of Biomedicine and Health, Huazhong Agricultural University, Wuhan, China.
- Hubei Clinical Research Center for Precise Diagnosis and Treatment of Liver Cancer, Taihe Hospital, Hubei University of Medicine, Shiyan, Hubei, China.
Zitieren
APA
Shen, W., Hu, F., Lei, P., & Tang, Y. (2023). Applications of CRISPR screening to lung cancer treatment. Frontiers in Cell and Developmental Biology, 11. https://doi.org/10.3389/fcell.2023.1295555
Vancouver
Shen W, Hu F, Lei P, Tang Y. Applications of CRISPR screening to lung cancer treatment. Frontiers in Cell and Developmental Biology. 2023;11. doi:10.3389/fcell.2023.1295555
BibTeX
@article{Shen2023,
author = {Shen, Wanying and Hu, Fangli and Lei, Pan and Tang, Yijun},
title = {Applications of CRISPR screening to lung cancer treatment},
journal = {Frontiers in Cell and Developmental Biology},
year = {2023},
volume = {11},
doi = {10.3389/fcell.2023.1295555}
}
EUVIMED